Contact
Contact page
Category & trade
Primary
pharmaceutical-drugs · embed-ft 0.51
Tree path
Medical Health › Pharmaceutical Drugs
Group (tier-1)
Tech stack
AI readiness
AI-Readiness score
34 / 100 · partial · see similar
AI training policy
allowed
Terms of Service
found · https://incyte.com/legal-notice
AI-bot protection
AI files
llms.txt ai.txt humans.txt robots.txt
Compliance (GEO / GDPR)
TLD
Overview
Title
Polycythemia Vera, Myelofibrosis, Acute & Chronic Graft-Versus-Host Disease | Jakafi®/Jakafi XR™ (ruxolitinib)
Description
Learn about Jakafi®/Jakafi XR™ (ruxolitinib) – Used to treat adults with polycythemia vera who have taken hydroxyurea and it did not work well enough or they could not tolerate it, and adults with certain types of myelofibrosis. Jakafi is used to treat adults and children 12 years of age and older with acute graft-versus-host disease (GVHD) who have taken corticosteroids and they did not work well enough. Jakafi is also used to treat adults and children 12 years of age and older with chroni
Final URL
Language
en (html)
Scanned at
2026-07-20 01:35:27